characterized by a slow growth rate, absence of pigmentaa fitness cost in the absence of the antibiotic [1, 2]. tion, a reduced range of carbohydrate utilization, and fail-
we see is consistent with normal mutation rates in combination with selection by the presence of gentamicin.
We examined whether the rate of emergence of SCVs could
Results and Discussion
be explained by growth from the original inoculating populaThe acquisition of antibiotic resistance through genetic tion using two strategies. The frequency of SCVs in the mutation is frequently associated with a fitness cost in population before exposure to gentamicin was found to be the absence of the antibiotic [1, 2] . The evolution of less than 10
Ϫ5
. In order to reach the frequency observed at fitness-compensatory mechanisms through second-site 30 min, the SCVs would need to have a mean generation mutations has been defined in bacteria during serial pastime of approximately 3 min, and over 7 hr, the mean generasage in broth culture or experimental animals, but the tion time would have to be 28 min. However, the actual relative fitness of the resulting strains often remains remean generation time over 7 hr under the same conditions duced [2] [3] [4] . A reversible antibiotic resistance mechanism was found to be 3.5 hr. The second strategy was based on that is not associated with a potentially lasting fitness cost the fact that, if the emergence of SCVs depended on their is likely to be favored by selection.
presence in the inoculum, reducing the numbers of bacteria introduced into the gentamicin broth should reduce their Phenotypic variants of Staphylococcus aureus, known as frequency within the population. After reducing the bacterial small colony variants (SCVs), are believed to have a defect inoculum 100-fold, the proportion of SCVs in the population in electron transport and are resistant to aminoglycosides by virtue of poor drug uptake [5, 6] . These variants are after 24 hr of incubation increased from 32% Ϯ 4.5% to The effect on the growth of S. aureus upon exposure to gentamicin. (a) A growth curve of S. aureus in the presence or absence of a sublethal dose of gentamicin. The data is represented as the mean cfu/ml for five S. aureus strains Ϯ standard error of the mean.
(b) A graph showing the emergence of SCVs (as a percentage of the total population) after exposure to gentamicin over 24 hr. The data is represented as the mean value for five S. aureus strains Ϯ standard error of the mean.
68.8% Ϯ 14% (p Ͻ 0.001). This is consistent with switching switching through cyclical exposure to gentamicin and gentamicin-free media five times (Figure 2 ). This unequivoto the SCV phenotype combined with a decreased chance of including stable gentamicin-resistant mutants in the inoccally demonstrates a mechanism by which S. aureus can switch between gentamicin-sensitive and gentamicin-resisulum. Together, these data suggest that the SCVs cannot have emerged as a result of the replication of existing variants tant forms. We extended our analysis to 30 independent isolates of S. aureus associated with either nasal carriage in in the inoculating population and must have emerged by switching from the wild-type to the SCV phenotype.
healthy volunteers (n ϭ 15) or invasive disease (n ϭ 15, inclusive of the 5 initial isolates). The emergence of SCVs was demonstrated for all isolates, suggesting that this mechTo test whether this was a two-way and repeatable switch, we picked SCVs from each of the five original isolates anism is common within natural populations of S. aureus. and exposed them to antibiotic-free media. In all cases, SCV clones were found to spontaneously revert to the wildHaving established the existence of a switching mechanism, we next determined whether the switch was spontype phenotype. Rechallenge of revertant clones with gentamicin resulted in the emergence of SCVs at the taneous or induced by gentamicin. No SCVs were observed at any time during 24 hr of growth in the absence same frequency as from the original wild-type population. This phenomenon was fully repeatable with induction of of gentamicin, supporting the hypothesis of an inducible switch. However, high-frequency spontaneous switching mycin or spectinomycin. It is possible that only certain members of the aminoglycoside family can induce switchand antibiotic-imposed selection of resistant SCVs might ing to SCVs or that concentrations other than the MIC explain these data if the rate of switching from wild-type may be required to induce this switching event. We examto SCV was lower than the rate of switching from SCV to ined the effects of varying the concentration of gentamicin revertant. Our estimates suggest that the rate of switching on the emergence of SCVs. The MIC of SCV was found from wild-type to SCV (95% confidence interval [CI] :
to be 20-fold higher than wild-type/revertants (which had 0.07%-0.3% cells/generation) is at least an order of magnithe same MICs). Growth in concentrations above the MIC tude greater than the rate of switching from an SCV to a of SCV resulted in death of the entire inoculum, while revertant (95% CI: 0.0009%Ϫ0.04% cells/generation). We the emergence of SCVs was favorably selected by a contherefore consider it unlikely that our data can be excentration between the MIC of wild-type and SCV. Conplained by a high-rate switch that usually favors the sensicentrations below the MIC of wild-type initially induced tive variant in the absence of gentamicin, but which allows switching, but by 24 hr, the SCVs were outgrown by selection and capture of the resistant population in the sensitive wild-type. It has been suggested previously that presence of gentamicin. Whether or not the switch from the SCV phenotype confers increased resistance to other SCV to revertant is spontaneous or induced by the absence antibiotics [17] . We found that SCVs were no more resisof antibiotic is as yet unclear.
tant to methicillin, vancomycin, erythromycin, ciprofloxacin, rifampicin, fusidic acid, and tetracycline. To examine whether stresses other than gentamicin induce switching to SCVs, the five S. aureus isolates were
We next considered whether the ability to switch between grown under either acidic, oxidative, anaerobic, starvation, gentamicin-resistant and -sensitive forms provided a fitor temperature stress. SCVs were not induced by these ness advantage over mutants of S. aureus that are stably conditions. Consistent with this was the finding that the resistant to gentamicin. Mutants with stable gentamicin general stress-response sigma factor SigB did not play a resistance were isolated from the five S. aureus isolates role in the switching mechanism, as a strain deficient in and were found to have a 40-fold increase in MIC relative SigB switched to the same degree as its parent (SigB ϩ ) to wild-type. SCVs had a growth rate disadvantage relative strain [15] . Bacteria were also grown in the minimum to the stable mutants when grown in the presence of inhibitory concentration (MIC) [16] of either methicillin, gentamicin, as can be seen in Figure 1 by the outgrowth vancomycin, erythromycin, ciprofloxacin, chlorampheniof SCVs by resistant mutants after 14 hr of exposure col, streptomycin, spectinomycin, amikacin, kanamycin, to gentamicin. However, gentamicin-sensitive revertants or tobramycin. The only conditions tested that led to outcompeted stable gentamicin-resistant strains when grown in antibiotic-free media where the stable mutants switching to SCVs was growth in the presence of strepto-had a relative fitness of 0.44 (standard error of 0.05; paired Our second proposed mechanism is that a recombinational switch is causing an alteration at the level of DNA set test, p Ͻ 0.0001) [18] . We next examined whether the ability to switch during cycling conditions in the presence quence. The frequency of recombination causing the phase-variation of the type 1 fimbriae of E. coli can be or absence of gentamicin was sufficient to allow the revertant phenotype to dominate once the antibiotic was directionally modulated in response to alterations in the level of DNA supercoiling, which in itself is caused by permanently removed. After two successive cycles in the presence and absence of gentamicin, 54% (Ϯ15%) of the many environmental factors [20] . We propose that aminoglycosides, either directly or indirectly, may induce a repopulation was found to be sensitive to gentamicin. By adopting the SCV phenotype on exposure to gentamicin, combination event resulting in the SCV phenotype. The long-term association between S. aureus and aminoglyco-S. aureus acquires antibiotic resistance together with a reduced rate of growth. The removal of gentamicin from side-producing microbes and the fitness costs associated with permanent antibiotic resistance make the evolution the bacterial environment induces bacteria to revert to the wild-type phenotype, and, in so doing, avoids the by natural selection of such an environmentally induced recombination event feasible. acquisition of a fitness disadvantage associated with resistance by mutation.
Materials and methods
Gentamicin is not routinely used to treat serious S. aureus SCV emergence assays BHI (brain heart infusion) broth containing the published breakpoint MIC infections [19] , and so the use of gentamicin as a therapeutic of gentamicin, 2 g/ml (GIBCO BRL,) was inoculated with 5 ϫ 10 6 cfu/ agent is unlikely to have been the selective force responsiml (colony forming units/ml) of S. aureus strains that had grown overnight ble for the evolution of the switching mechanism. Gentamiat 37ЊC in air on horse blood agar. The broth cultures were incubated cin is naturally produced by Micromonaspora species, and with constant rotation in air at 37ЊC. Aliquots were removed at allotted time points, serially diluted, and plated onto antibiotic-free blood agar.
streptomycin and spectinomycin are produced by StreptoSCVs were identified by having a colony size a tenth of the size of a myces species, so we hypothesize that long-term interactions the drug was discovered, presumably again in response to interactions between microbial species in the environment.
Frequency of SCVs in an unstressed population

Evolutionary development of this switch suggests that
To measure the prevalence of SCVs in a population of S. aureus, bacteria other bacterial pathogens may have evolved similar stratewere grown overnight on blood agar at 37ЊC. The bacteria were diluted gies, a possibility that merits investigation.
and plated onto fresh blood agar such that individual colonies of SCVs, if present, could be identified, i.e.: 200-500 cfu/plate. A total of 10 5 cfu were plated, and no SCVs were identified.
These data provide the first demonstration that bacteria can switch between antibiotic-resistant and -sensitive Growth rate of SCVs forms in response to antibiotic pressure. We are working
The frequency of SCVs in the inoculating population is Ͻ 10 Ϫ5 , so if we to elucidate the mechanism, but it is currently unclear how assign this a value of 10 Ϫ6 , the number of SCVs introduced into the BHI it compares with other phenotypic switches in bacteria. In with gentamicin was 5 cfu/ml. After 30 min, the SCV make up 0.1% of 1.4 ϫ 10 6 cfu/ml. The number of doublings from 5 to 1.4 ϫ 10 3 is approxithe absence of mechanistic detail, we propose two models. The first is that an epigenetic event occurs and alters gentamicin of 3.75 min. After 7 hr, the SCV make up 27% of 5 ϫ 10 5 the regulation of a subset of genes, resulting in the SCV cfu/ml, which is 1.4 ϫ 10 5 cfu/ml. The number of doublings from 5 to phenotype. Although SCVs revert once gentamicin is re-1.4 ϫ 10 5 is approximately 15. Therefore, the mean generation time for SCVs to have grown from the inoculating population over 7 hr would be moved, it is not an immediate or a population-wide event, 28 min. SCVs from each of the five S. aureus strains were grown overnight and so the possibility that a regulatory change could conat 37ЊC on blood agar. BHI containing 2 g/ml gentamicin was inoculated tinue to exert effects through several generations is intriwith 1 ϫ 10 6 SCVs cfu/ml; after 7 hr of incubation, the cfu/ml for each guing. For this to be true, the effector protein would strain was estimated by diluting and plating onto fresh blood agar and was found to be 4.2 ϫ 10 6 (Ϯ3 ϫ 10 5
). This suggests that SCVs grown in need to have an extremely long half-life to result in the BHI with gentamicin have a mean generation time of 3.5 hr.
observed maintenance of the phenotype once gentamicin is removed. It would also need to be highly active at very
Reversion assay
low concentrations, such that titration following multiple
The experiment to measure the rate of switching from SCV to revertant cell divisions ultimately leads to a state in which the phenotype was carried out as described above for the SCV emergence threshold concentration for activity is maintained in one assay with the following exceptions: the BHI broth contained no antibiotics; the inoculating population consisted of SCVs; and the assay was daughter cell (which maintains the SCV phenotype) but continued for an additional 24 hr.
lost in another (resulting in reversion), thereby explaining why reversion is not population wide. We do not believe
Estimation of switching rates
a protein with such activity has previously been characterAccurately estimating the rate of switching (% cells/generation) from wildized and suggest that this would be a novel mechanism type to SCV is problematic because the generation time of the wild-type may be extended indefinitely by the antibiotic. We provide a conservative for antibiotic resistance. 
